-
1by Vermeer, Niels Published in De Economist (Netherlands) (01.09.2016)“...This study examines the sensitivity of the expected retirement age to standard retirement ages in pension overviews (age anchors) via a survey. The results...”
-
2“...We analyse unique Dutch survey data on the public's opinions on what are demanding occupations, on whether it is justified that someone with a demanding...”
-
3by Vermeer, Niels van Rooij, Maarten van Vuuren, Daniel Published in De Economist (Netherlands) (01.12.2019)“...Using a specifically designed survey, we investigate the role of the social network in shaping workers’ retirement preferences. We find that the preferred...”
-
4“...Retirement is often concentrated at specific ages-in particular the 'normal retirement age' and an 'early retirement age'. Financial incentives cannot fully...”
-
5by Vermeer, Niels S Straus, Sabine M. J. M Mantel-Teeuwisse, Aukje K Domergue, Francois Egberts, Toine C. G Leufkens, Hubert G. M De Bruin, Marie L Published in Drug safety (01.08.2013)“...Adverse drug reactions (ADRs) of biopharmaceuticals can be batch or product specific, resulting from small differences in the manufacturing process. Detailed...”
-
6by Klein, Kevin Scholl, Joep H G Vermeer, Niels S Broekmans, Ané W Van Puijenbroek, Eugène P De Bruin, Marie L Stolk, Pieter Published in Drug safety (01.02.2016)“...INTRODUCTION AND OBJECTIVE: Pharmacovigilance requirements for biologics mandate that EU Member States shall ensure that any biologic that is the subject of a...”
-
7by Vermeer, Niels S Ebbers, Hans C Straus, Sabine M J M Leufkens, Hubert G M Egberts, Toine C G De Bruin, Marie L Published in Pharmacoepidemiology and drug safety (2016)“...Background and Objective: The availability of accurate product-specific exposure information is essential in the pharmacovigilance of biologicals, because...”
-
9
-
10by Vermeer, N.S Giezen, Thijs Zastavnik, S Wolff-Holz, E Hidalgo-Simon, A Published in Clinical pharmacology and therapeutics (01.01.2019)“...textabstractBiologicals are established treatment options that require pharmacovigilance adapted to their specific nature, including the need for products to...”
-
11“...Does brownfield redevelopment warrant government support? We explore several external benefits in an urban general equilibrium framework. Preferences are...”
-
12
-
14by Vermeer, Niels S Spierings, Irina Mantel-Teeuwisse, Aukje K Straus, Sabine MJM Giezen, Thijs J Leufkens, Hubert GM Egberts, Toine CG De Bruin, Marie L Published in Expert opinion on drug safety (01.01.2015)“...Introduction: Traceability is important in the postmarketing surveillance of biologicals, since changes in the manufacturing process may give rise to product-...”
-
15
-
16by Vermeer, Niels S Ebbers, Hans C Straus, Sabine M J M Leufkens, Hubert G M Egberts, Toine C G De Bruin, Marie L Published in Pharmacoepidemiology and drug safety (2016)“...Background and Objective: The availability of accurate product-specific exposure information is essential in the pharmacovigilance of biologicals, because...”
-
17
-
18by Vermeer, Niels S Spierings, Irina Mantel-Teeuwisse, Aukje K Straus, Sabine Mjm Giezen, Thijs J Leufkens, Hubert Gm Egberts, Toine Cg De Bruin, Marie L Published in Expert opinion on drug safety (01.01.2015)“...INTRODUCTION: Traceability is important in the postmarketing surveillance of biologicals, since changes in the manufacturing process may give rise to product-...”
-
19“...Does brownfield redevelopment warrant government support? We explore several external benefits in an urban general equilibrium framework. Preferences are...”